B+
Bull case
25%
Probability
Target price
$5.50
+33.3% vs current
SANG
SangomaANasdaq / Technology Hardware & Equipment
Last Price
At close
2026-07-18
AI scenario view
RankAlpha Sentiment CodexMost likely
B
Base case
50%
Probability
Target price
$4.20
+1.8% vs current
B-
Bear case
25%
Probability
Target price
$3.00
-27.3% vs current
AI sentiment snapshot
Latest data as of 2026-07-11
Recent news sentiment (30D)
-20.7
Negative
Company
-
Unavailable
Macro
-21.4
Negative
Pulse
+18.0
Positive
Sentiment proxy
+48.9
Score
AI commentary
Low-conviction monitoring view. Primary company sources now confirm the May 13 strategic-review announcement and guidance cut, the April 1 NCIB renewal, and the June 4 CFO transition. That improves source quality versus a SERP-only read, but coverage remains thin, there are no usable SEC excerpts in the packet, no stored earnings transcript was provided, and the deterministic prior stays neutral with slightly negative expected returns over 20d-120d and an evidence-quality score of 0.32. Secondary post-earnings coverage was negative on revisions, so sentiment remains cautious rather than constructive.
RankAlpha Sentiment Codex - 2026-07-11
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-09-30eventStrategic review is still the main rerating pathHigh impact
Sangoma's May 13, 2026 company results release said the board engaged ATB Cormark to evaluate strategic alternatives after inbound expressions of interest, but also said there is no fixed timeline and no assurance of any transaction. That keeps M&A or partnership optionality alive, but the lack of a defined process limits conviction. [#IR-2026-05-13]
2026-09-30catalystHolding the lowered fiscal 2026 guide is the next operating proof pointHigh impact
In the same May 13, 2026 release, Sangoma revised fiscal 2026 guidance to $204-$205 million of revenue and 15%-16% adjusted EBITDA margin from the narrower February range of $205-$208 million and 17%-18%, citing revenue timing, product mix, and macro conditions. The next meaningful test is whether the company can hold that lower bar into year-end reporting. [#IR-2026-05-13]
2027-04-05catalystNCIB and debt paydown provide some downside support, not a full thesis changeMedium impact
Sangoma's April 1, 2026 NCIB renewal allows repurchases of up to 1,663,939 shares through April 5, 2027, while the May 13, 2026 results release also showed debt down to $32.5 million and cash of $15.2 million after loan repayment and buybacks. That supports valuation and balance-sheet stability, but management also said repurchase timing depends on valuation, liquidity, and potential acquisitions. [#IR-2026-04-01] [#IR-2026-05-13]
Recommendation
N/A
No formal recommendation provided.
As of 2026-07-11 • Updated nightlySource: Internal modelMethodology